This site is intended for healthcare professionals only
LoginRegister

Urology Dialogues

Following Checkmate-274 trial, FDA approves adjuvant Nivolumab for high-risk Urothelial Carcinoma

Following Checkmate-274 trial, FDA approves adjuvant Nivolumab for high-risk Urothelial Carcinoma

Urothelial carcinoma (UC), is the most common type of bladder cancer in adults. In addition to the bladder, UC can occur in other parts of the urinary...
View All

Latest News and Guidelines

Residual benign prostate glandular tissue not tied to detectable PSA after radical prostatectomy: Study

Residual benign prostate glandular tissue not tied to detectable PSA after radical prostatectomy:...

Fluctuating BMI linked to poor prognosis in Chronic Kidney Disease: Study

Fluctuating BMI linked to poor prognosis in Chronic Kidney Disease: Study

Delaying fatherhood reduces success of assisted reproduction technology: Study

Delaying fatherhood reduces success of assisted reproduction technology: Study

Dapagliflozin reduces risk for hyperkalemia in HFrEF patients treated with MRAs: Study

Dapagliflozin reduces risk for hyperkalemia in HFrEF patients treated with MRAs: Study

Acupuncture effectively improves symptoms in chronic prostatitis patients: Study

Acupuncture effectively improves symptoms in chronic prostatitis patients: Study

Prolonged use of Dulaglutide reduces incidence of erectile dysfunction in men with T2DM: Study

Prolonged use of Dulaglutide reduces incidence of erectile dysfunction in men with T2DM: Study

View All
X